Jim Boonyaratanakornkit
Overview
Explore the profile of Jim Boonyaratanakornkit including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
771
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kinoshita H, Walti C, Webber K, Pezzella G, Jensen-Wachspress M, Lang H, et al.
Transplant Cell Ther
. 2025 Mar;
PMID: 40032074
Chimeric antigen receptor-modified T (CAR-T) cell therapies are gaining wider use in relapsed and refractory malignancies. However, data on vaccination in this population is lacking. We evaluated T cell responses...
2.
Haidar G, Thomas S, Loubet P, Baker R, Benfield T, Boonyaratanakornkit J, et al.
Lancet Infect Dis
. 2025 Feb;
PMID: 40015292
Background: Sipavibart is an anti-spike monoclonal antibody that neutralises SARS-CoV-2 with exceptions, including Phe456Leu-containing variants (eg, KP.2* and KP.3*). This trial assessed sipavibart efficacy and safety for prevention of symptomatic...
3.
Phelps A, Pazos-Castro D, Urselli F, Grydziuszko E, Mann-Delany O, Fang A, et al.
Nat Protoc
. 2024 Dec;
PMID: 39719506
No abstract available.
4.
Scharffenberger S, Wan Y, Homad L, Kher G, Haynes A, Poudel B, et al.
Cell Rep
. 2024 Oct;
43(10):114811.
PMID: 39383036
Respiratory syncytial virus (RSV) causes lower respiratory tract infections with significant morbidity and mortality at the extremes of age. Vaccines based on the viral fusion protein are approved for adults...
5.
Bodansky A, Yu D, Rallistan A, Kalaycioglu M, Boonyaratanakornkit J, Green D, et al.
J Clin Invest
. 2024 May;
134(13).
PMID: 38753445
Given the global surge in autoimmune diseases, it is critical to evaluate emerging therapeutic interventions. Despite numerous new targeted immunomodulatory therapies, comprehensive approaches to apply and evaluate the effects of...
6.
Boonyaratanakornkit J, Wang Q, Nader A, Kimball L, Stevens-Ayers T, Levkova M, et al.
J Infect Dis
. 2024 May;
230(3):670-679.
PMID: 38743457
Background: Monoclonal antibodies (mAbs) are utilized broadly to treat cancer and infectious diseases, and mAb exposure (serum concentration over time) is one predictor of overall treatment efficacy. Herein, we present...
7.
Phelps A, Pazos-Castro D, Urselli F, Grydziuszko E, Mann-Delany O, Fang A, et al.
Nat Protoc
. 2024 Jan;
19(3):727-751.
PMID: 38243093
B cells generate antibodies that provide protection from infection, but also cause pathology in autoimmune and allergic conditions. Antigen-specific B cells can be detected by binding their surface antibody receptors...
8.
Bodansky A, Yu D, Rallistan A, Kalaycioglu M, Boonyaratanakornkit J, Green D, et al.
medRxiv
. 2024 Jan;
PMID: 38196603
The prevalence and burden of autoimmune and autoantibody mediated disease is increasing worldwide, yet most disease etiologies remain unclear. Despite numerous new targeted immunomodulatory therapies, comprehensive approaches to apply and...
9.
Fitzpatrick K, Degefu H, Poljakov K, Bibby M, Remington A, Searles T, et al.
J Immunol
. 2023 Mar;
210(8):1156-1165.
PMID: 36883850
The study of Ag-specific lymphocytes has been a key advancement in immunology over the past few decades. The development of multimerized probes containing Ags, peptide:MHC complexes, or other ligands was...
10.
Doll M, Waghmare A, Heit A, Levenson Shakoor B, Kimball L, Ozbek N, et al.
JAMA Netw Open
. 2023 Feb;
6(2):e231181.
PMID: 36853602
Importance: The US arrival of the Omicron variant led to a rapid increase in SARS-CoV-2 infections. While numerous studies report characteristics of Omicron infections among vaccinated individuals or persons with...